Skip to Content

PAR 730 (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)

Pill with imprint PAR 730 is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Par Pharmaceutical, Inc..

Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAR 730

Aspirin and Extended-Release Dipyridamole

Imprint
PAR 730
Strength
25 mg / 200 mg
Color
Red & White
Size
24.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Platelet aggregation inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
49884-0007
Inactive Ingredients
lactose anhydrous, alginic acid, corn starch, stearic acid, povidone, triacetin, magnesium silicate, tartaric acid, acacia, gelatin, sodium lauryl sulfate, titanium dioxide, FD&C Red No. 40, FD&C Yellow No. 6, potassium hydroxide, xanthan gum, shellac, hypromelloses, ferric oxide red, ferric oxide yellow, water, ethylcelluloses, silicon dioxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.